Richard Beckman

Richard Beckman

Company: Adverum

Job title: Chief Medical Officer

Seminars:

Showcasing ADVM-022 as a Treatment for Neovascular AMD 9:30 am

Wet AMD: the rationale for using gene therapy for treatment Utilizing aAV.7m8 vector for intravitreal administration and preclinical and clinical support for dosing Clinical experience with ADVM-022 in Wet AMDRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.